🚀 VC round data is live in beta, check it out!
Zentiva Valuation Multiples
Discover revenue and EBITDA valuation multiples for Zentiva and similar public comparables like MiMedx Group, Guizhou Sanli, Astria Therapeutics, Pharmicell and more.
Zentiva Overview
About Zentiva
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.
Founded
1962
HQ
Employees
1.1K
Website
Sectors
Financials (FY)
EV
$709M
Zentiva Financials
Zentiva reported last fiscal year revenue of $251M and EBITDA of $72M.
In the same fiscal year, Zentiva generated $148M in gross profit, $72M in EBITDA, and $56M in net income.
Zentiva P&L
In the most recent fiscal year, Zentiva reported revenue of $251M and EBITDA of $72M.
Zentiva expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $251M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $148M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 59% | XXX | XXX | XXX |
| EBITDA | — | XXX | $72M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 24% | XXX | XXX | XXX |
| Net Profit | — | XXX | $56M | XXX | XXX | XXX |
| Net Margin | — | XXX | 23% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Zentiva Stock Performance
Zentiva has current market cap of $710M, and enterprise value of $709M.
Market Cap Evolution
Zentiva's stock price is $1.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $709M | $710M | -0.6% | XXX | XXX | XXX | $0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialZentiva Valuation Multiples
Zentiva trades at 2.8x EV/Revenue multiple, and 9.8x EV/EBITDA.
Zentiva Financial Valuation Multiples
As of March 21, 2026, Zentiva has market cap of $710M and EV of $709M.
Equity research analysts estimate Zentiva's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Zentiva has a P/E ratio of 12.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $710M | XXX | $710M | XXX | XXX | XXX |
| EV (current) | $709M | XXX | $709M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 9.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 11.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.8x | XXX | XXX | XXX |
| P/E | — | XXX | 12.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 85.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Zentiva Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Zentiva Margins & Growth Rates
Zentiva's revenue in the last fiscal year grew by 17%.
Zentiva Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 26% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Zentiva Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MiMedx Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Guizhou Sanli | XXX | XXX | XXX | XXX | XXX | XXX |
| Astria Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharmicell | XXX | XXX | XXX | XXX | XXX | XXX |
| Abclon | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zentiva M&A Activity
Zentiva acquired XXX companies to date.
Last acquisition by Zentiva was on XXXXXXXX, XXXXX. Zentiva acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Zentiva
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialZentiva Investment Activity
Zentiva invested in XXX companies to date.
Zentiva made its latest investment on XXXXXXXX, XXXXX. Zentiva invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Zentiva
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Zentiva
| When was Zentiva founded? | Zentiva was founded in 1962. |
| Where is Zentiva headquartered? | Zentiva is headquartered in Romania. |
| How many employees does Zentiva have? | As of today, Zentiva has over 1K employees. |
| Is Zentiva publicly listed? | Yes, Zentiva is a public company listed on Bucharest Stock Exchange. |
| What is the stock symbol of Zentiva? | Zentiva trades under SCD ticker. |
| When did Zentiva go public? | Zentiva went public in 1998. |
| Who are competitors of Zentiva? | Zentiva main competitors are MiMedx Group, Guizhou Sanli, Astria Therapeutics, Pharmicell. |
| What is the current market cap of Zentiva? | Zentiva's current market cap is $710M. |
| What is the current revenue of Zentiva? | Zentiva's last fiscal year revenue is $251M. |
| What is the current EV/Revenue multiple of Zentiva? | Current revenue multiple of Zentiva is 2.8x. |
| Is Zentiva profitable? | No, Zentiva is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.